Americans Can’t Afford It.
Last week, an article was published by Jeremy Malcolm, senior global policy analyst for the Electronic Frontier Foundation, under the appropriate title, “How Big Pharma’s Shadow Regulation Censors the Internet.” Basically, Jeremy explains that due to drug company money and political influence in the United States, there are activities going on both in plain view and behind the scenes that are meant to curtail and even end access by Americans to lower cost medications being sold on the Internet.
I’ve been writing about this – albeit in less Internet policy, theoretical terms – for years and testified before and warned Congress in 2013 on this issue. About a month ago, I published an article on Circle ID, a source of news and opinion about Internet policy and governance, describing the actions of drug companies to dominate the Internet. My hope was to reach people just like Jeremy Malcolm at organizations like the Electronic Frontier Foundation (EFF). EFF is a non-governmental organization, founded in 1990 to defend civil liberties in the digital world. They champion “user privacy, free expression, and innovation through impact litigation, policy analysis, grassroots activism, and technology development.” Read about its awesome work and history here. (more…)
Tagged with: Alliance for Safe Online Pharmacies, Center for Safe Internet Pharmacies, Electronic Frontier Foundation, jeremy malcolm, LegitScript, NABP, shadow regulation, voluntary agreements
What Americans think about drug prices…
A new poll by Kaiser Family Foundation found that 44 million Americans find it difficult to afford medication. Also, 77% of Americans believe drug prices are unreasonable, up from 72% last year. On the other hand, most Americans did not have trouble affording their medications. Of the 55% of Americans who take medication, 73% say they can afford them, 26% say that its’ difficult. (I’m not sure why that doesn’t round to 100%).
Overwhelming majorities of Americans support policies, legislative reforms in most cases, to bring down prescription drug prices and have access lower cost medications from Canada. The most popular policy would be forcing pharmaceutical companies to be transparent about their pricing of medication. The next two most favored policies are allowing Medicare to negotiate drug prices and expanding personal importation of lower cost medication from Canada.
The Kaiser Poll was a nationally representative random survey of 1204 adults living in the U.S. Public and voter opinions on drug prices are just one part of the survey, albeit the main one: but the poll also covers voter opinions and data about health insurance generally, Obamacare, premiums, and deductibles.
The Kaiser Poll has very interesting political analyses relating to how a person will vote in the upcoming presidential election and the candidates’ positions on prescription drug costs and other healthcare issues. If interested, the positions of Hillary Clinton and Donald Trump are summed up on the blog of Prescription Justice. Both Clinton and Trump support expanding access to lower cost imported medications through personal importation, but Clinton has a much more ambitious plan, which is very much congruous with public opinion among Democratic and Republican voters.
Tagged with: Kaiser, poll
To affordable medication!
It’s a well-known fact that the pharmaceutical industry has the greatest lobbying prowess of any industry in America. That power enables them to drive law and policy here at home – including the creation and maintenance of laws that make it technically illegal to import lower cost medications from Canada and other countries. Such is the nature of political power in the United States. But things are different in the virtual world.
Big pharma is trying to have that same sway over the Internet in order to stop people from buying lower cost medications online – and they are having successes. But the Internet community and the access to medicines activists can team up to defeat them. In an article I published on Circle ID this week, I identify for the Internet community what it means to protect online access to safe and affordable medication.
Essentially, I propose that rules applied to medicine sales on the Internet should reflect the highest aspirations of human rights law, which hold that access to affordable medications are a human right. Under this perspective, companies, such as registries, registrars, online payment processors, and others, that control “access” to the Internet, should do everything they can to make sure Internet users have the widest possible online access to purchase medication they can afford. Who wouldn’t want that?
Talking to the New York Times!
Last week the New York Times published my Letter to the Editor in response to an article about Mylan’s despicable increase of the life-saving drug Epipen, which saves people from serious allergic reactions. In “An Outcry Over the Price of Epipen,” my Letter’s focus is really on Congress and the need for them to actually do something besides talk. I note that personal drug importation, which is already happening, should not just be tolerated as a technically illegal behavior for which patients are never prosecuted but encouraged using proper guidance so that people can afford the prescriptions they need.
The other Letters provide excellent contributions to the policy debate. Caroline Poplin, who is a doctor, lawyer and healthcare analyst (wow!), criticizes drug companies for their abuse of our patent laws and federal regulations that allow them to maximize profits over patients. She believes that where the market is producing “bad results” government ought to provide remedies.
Sarah fink writes that due to the price of Epipen, her serious allergic reaction forced the plane she was on to land! Here we learn that airlines started cutting back on keeping Epipens on places due to the price. This was my favorite Letter.
Again, check it out here.
Tagged with: EpiPen, letter, mylan, nytimes
Bring it on!
As noted on the top of this web page, this blog is about “Helping Americans Get the Truth About Prescription Savings”. From time to time, I’m afforded the honor of spreading the truth farther and wider than our blog, including this week in Morning Consult, an online journal covering the intersection of politics, policy and business. In “Americans Deserve the Truth about Lower Cost Prescriptions,” I articulate the simple reality that millions of Americans import lower cost and safe medication and that they have done so for 15 years when buying from the safest international online pharmacies, despite federal restrictions.
Against consumers is the multinational pharmaceutical industry, which, in protection of its profits, spends a good deal of time and money scaring Americans into not buying lower cost medication on the grounds that they are likely to get a fake or substandard drug. To them the Internet presents mostly dangers when it comes to buying affordable medication. They refer to safe international online pharmacies as “rogue” or “fake” – and that scares people.
Remember, we’re dealing with a crisis of high drug prices in America and there are safe international online pharmacies that provide immediate relief while we work out longer term solutions. The flip side of the Big Pharma narrative about “rogue online pharmacies” is plain to see as the truth for those who take the time to look. The role of the Internet in making it possible for a consumer to obtain an essential medication in another country that is not affordable locally should have us all talking about how to encourage online access to safe and affordable medication.
Tagged with: lower cost medication, morning consult, truth
“I represent safe and affordable imported medication. This bathwater is dangerous rogue pharmacy websites!”
Earlier this month, the U.S. Food and Drug Administration published a press release about Operation Pangea, an annual global initiative led by INTERPOL “to combat the unlawful sale and distribution of illegal and potentially counterfeit medical products on the internet.” This is the ninth annual operation, and each year I wonder if FDA will throw the baby out with the bathwater.
There are, according to FDA’s own sources, tens of thousands of drug-selling websites. Most of them are considered “rogue” by PharmacyChecker.com. Where the FDA and Operation Pangea successfully shut down sites (whether lawful or not) that intentionally sell counterfeit medications, or even online pharmacies that sell real medications but without the qualifications or pharmacy safety protocols to do so, we applaud their actions. Shutting down dangerous online pharmacies – throwing out the bathwater – is noble.
In February of last year we submitted a policy paper that I wrote to congressional committees with jurisdiction over laws and regulations that affect access to safe and affordable medications. Entitled “Online Pharmacies, Persona Drug Importation, and Public Health,” I argued that safe international online pharmacies are a boon to public health because they enable consumers to afford prescribed medications, and that overzealous enforcement of drug importation regulation could negatively affect access to those sites. Actions taken by FDA and through Operation Pangea would seem to cross the line from public health to Big Pharma profit protection where they curtail access to the safest international online pharmacies, which is throwing out the baby.
Tagged with: Interpol, pangea